<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40954052</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0255-2930</ISSN><JournalIssue CitedMedium="Print"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion</Title><ISOAbbreviation>Zhongguo Zhen Jiu</ISOAbbreviation></Journal><ArticleTitle>[Moxibustion at different temperatures for cognitive impairment in type 2 diabetes mellitus: a randomized controlled trial].</ArticleTitle><Pagination><StartPage>1233</StartPage><EndPage>1240</EndPage><MedlinePgn>1233-1240</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.13703/j.0255-2930.20240903-k0006</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To observe the effects of moxibustion at different temperatures on cognitive function and blood glucose levels in patients with cognitive impairment associated with type 2 diabetes mellitus (T2DM).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 66 T2DM patients with cognitive impairment were randomly assigned to a high-temperature group (22 cases, 1 case dropped out, 1 case was eliminated), a medium-temperature group (22 cases, 2 cases were eliminated), and a low-temperature group (22 cases, 2 cases were eliminated). All groups received moxibustion at Baihui (GV20), Dazhui (GV14), and Shenting (GV24) based on their existing glycemic control treatment. Moxibustion temperatures were maintained at 44-46 &#x2103; (high-temperature group), 41-43 &#x2103; (medium-temperature group), and 38-40 &#x2103; (low-temperature group), respectively, for 20 min per session, every other day, 3 times a week for 3 months. The Montreal cognitive assessment (MoCA) score, mini-mental state examination (MMSE) score, short-term memory (STM) accuracy and average reaction time, Rey-Osterrieth complex figure (ROCF) score, fasting plasma glucose (FPG), and glycated hemoglobin (HbA1c) were assessed before and after treatment. Clinical efficacy was evaluated after treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">After treatment, MMSE scores in all three groups were higher than those before treatment (<i>P</i>&lt;0.05). In the high-temperature group, the total MoCA score and the scores of visuospatial and executive function, memory and delayed recall, attention, naming, language, and abstraction were higher than those before treatment (<i>P</i>&lt;0.05); the scores of ROCF copy, immediate recall, and delayed recall were higher than those before treatment (<i>P</i>&lt;0.05); the HbA1c level was lower than that before treatment (<i>P</i>&lt;0.05). In the medium-temperature group, the total MoCA score and the scores of memory and delayed recall, attention, and language were higher than those before treatment (<i>P</i>&lt;0.05). STM accuracy was higher than before treatment (<i>P</i>&lt;0.05), and STM average reaction time was shorter than before treatment (<i>P</i>&lt;0.05) in both the high-temperature and medium-temperature groups. After treatment, the total MoCA score and the scores of visuospatial and executive function, memory and delayed recall, attention, and language in the high-temperature group were higher than those in the medium- and low-temperature groups (<i>P</i>&lt;0.05); MMSE score, STM accuracy, and ROCF immediate recall and delayed recall scores were higher than those in the medium- and low-temperature groups (<i>P</i>&lt;0.05); STM average reaction time was shorter than that in the medium- and low-temperature groups (<i>P</i>&lt;0.05); HbA1c level was lower than that in the low-temperature group (<i>P</i>&lt;0.05). The total MoCA score, attention score, and MMSE score in the medium-temperature group were higher than those in the low-temperature group (<i>P</i>&lt;0.05), and STM average reaction time was shorter than that in the low-temperature group (<i>P</i>&lt;0.05). There were no statistically significant differences in FPG within or between the three groups before and after treatment (<i>P</i>&gt;0.05). The total effective rates were 75.0% (15/20) in the high-temperature group, 50.0% (10/20) in the medium-temperature group, and 15.0% (3/20) in the low-temperature group; the total effective rate in the high-temperature group was significantly higher than that in the low-temperature group (<i>P</i>&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Moxibustion at different temperatures has a dose-effect relationship in treating cognitive impairment in T2DM patients. A temperature range of 44-46 &#x2103; is more effective in improving cognitive function and stabilizing average blood glucose levels over 2-3 months.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Anhui University of CM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Yuhao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Anhui University of CM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Aihong</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Second Department of Acupuncture-Moxibustion and Rehabilitation, First Affiliated Hospital of Anhui University of CM, Hefei 230031.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lele</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Anhui University of CM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Anhui University of CM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qunwei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Anhui University of CM, Hefei 230031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Hongyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Second Department of Acupuncture-Moxibustion and Rehabilitation, First Affiliated Hospital of Anhui University of CM, Hefei 230031.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhongguo Zhen Jiu</MedlineTA><NlmUniqueID>8600658</NlmUniqueID><ISSNLinking>0255-2930</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009071" MajorTopicYN="Y">Moxibustion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015669" MajorTopicYN="N">Acupuncture Points</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b>&#x89c2;&#x5bdf;&#x4e0d;&#x540c;&#x6e29;&#x5ea6;&#x827e;&#x7078;&#x5bf9;2&#x578b;&#x7cd6;&#x5c3f;&#x75c5;&#xff08;T2DM&#xff09;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x51cf;&#x9000;&#x60a3;&#x8005;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x53ca;&#x8840;&#x7cd6;&#x6c34;&#x5e73;&#x7684;&#x5f71;&#x54cd;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b>&#x5c06;66&#x4f8b;T2DM&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x51cf;&#x9000;&#x60a3;&#x8005;&#x968f;&#x673a;&#x5206;&#x4e3a;&#x9ad8;&#x6e29;&#x7ec4;&#xff08;22&#x4f8b;&#xff0c;&#x8131;&#x843d;1&#x4f8b;&#x3001;&#x5254;&#x9664;1&#x4f8b;&#xff09;&#x3001;&#x4e2d;&#x6e29;&#x7ec4;&#xff08;22&#x4f8b;&#xff0c;&#x5254;&#x9664;2&#x4f8b;&#xff09;&#x548c;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;22&#x4f8b;&#xff0c;&#x5254;&#x9664;2&#x4f8b;&#xff09;&#x3002;3&#x7ec4;&#x5747;&#x5728;&#x539f;&#x6709;&#x964d;&#x7cd6;&#x65b9;&#x6848;&#x57fa;&#x7840;&#x4e0a;&#x4e88;&#x827e;&#x7078;&#x767e;&#x4f1a;&#x3001;&#x5927;&#x690e;&#x548c;&#x795e;&#x5ead;&#xff0c;&#x9ad8;&#x6e29;&#x7ec4;&#x3001;&#x4e2d;&#x6e29;&#x7ec4;&#x3001;&#x4f4e;&#x6e29;&#x7ec4;&#x5206;&#x522b;&#x7ef4;&#x6301;&#x7078;&#x6e29;&#x5728;44~46 &#x2103;&#x3001;41~43 &#x2103;&#x548c;38~40 &#x2103;&#xff0c;&#x6bcf;&#x6b21;20 min&#xff0c;&#x9694;&#x65e5;1&#x6b21;&#xff0c;&#x6bcf;&#x5468;3&#x6b21;&#xff0c;&#x8fde;&#x7eed;&#x6cbb;&#x7597;3&#x4e2a;&#x6708;&#x3002;&#x5206;&#x522b;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#x540e;&#x89c2;&#x5bdf;3&#x7ec4;&#x60a3;&#x8005;&#x8499;&#x7279;&#x5229;&#x5c14;&#x8ba4;&#x77e5;&#x8bc4;&#x4f30;&#x91cf;&#x8868;&#xff08;MoCA&#xff09;&#x8bc4;&#x5206;&#x3001;&#x7b80;&#x6613;&#x7cbe;&#x795e;&#x72b6;&#x6001;&#x91cf;&#x8868;&#xff08;MMSE&#xff09;&#x8bc4;&#x5206;&#x3001;&#x77ed;&#x65f6;&#x8bb0;&#x5fc6;&#x7f16;&#x7801;&#x8bd5;&#x9a8c;&#xff08;STM&#xff09;&#x6b63;&#x786e;&#x7387;&#x548c;&#x5e73;&#x5747;&#x53cd;&#x5e94;&#x65f6;&#x95f4;&#x3001;&#x590d;&#x6742;&#x56fe;&#x5f62;&#x6d4b;&#x9a8c;&#xff08;ROCF&#xff09;&#x8bc4;&#x5206;&#x53ca;&#x7a7a;&#x8179;&#x8840;&#x7cd6;&#xff08;FPG&#xff09;&#x3001;&#x7cd6;&#x5316;&#x8840;&#x7ea2;&#x86cb;&#x767d;&#xff08;HbA1c&#xff09;&#x6570;&#x503c;&#xff0c;&#x5e76;&#x4e8e;&#x6cbb;&#x7597;&#x7ed3;&#x675f;&#x540e;&#x8bc4;&#x5b9a;&#x4e34;&#x5e8a;&#x7597;&#x6548;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b>&#x6cbb;&#x7597;&#x540e;&#xff0c;3&#x7ec4;&#x60a3;&#x8005;MMSE&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff1b;&#x9ad8;&#x6e29;&#x7ec4;&#x60a3;&#x8005;MoCA&#x603b;&#x5206;&#x53ca;&#x89c6;&#x7a7a;&#x95f4;&#x4e0e;&#x6267;&#x884c;&#x529f;&#x80fd;&#x3001;&#x8bb0;&#x5fc6;&#x4e0e;&#x5ef6;&#x8fdf;&#x8bb0;&#x5fc6;&#x80fd;&#x529b;&#x3001;&#x6ce8;&#x610f;&#x529b;&#x3001;&#x547d;&#x540d;&#x80fd;&#x529b;&#x3001;&#x8bed;&#x8a00;&#x80fd;&#x529b;&#x3001;&#x62bd;&#x8c61;&#x80fd;&#x529b;&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;ROCF&#x590d;&#x5236;&#x3001;&#x77ac;&#x65f6;&#x56de;&#x5fc6;&#x3001;&#x5ef6;&#x8fdf;&#x56de;&#x5fc6;&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;HbA1c&#x503c;&#x4f4e;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff1b;&#x4e2d;&#x6e29;&#x7ec4;&#x60a3;&#x8005;MoCA&#x603b;&#x5206;&#x53ca;&#x8bb0;&#x5fc6;&#x4e0e;&#x5ef6;&#x8fdf;&#x8bb0;&#x5fc6;&#x80fd;&#x529b;&#x3001;&#x6ce8;&#x610f;&#x529b;&#x3001;&#x8bed;&#x8a00;&#x80fd;&#x529b;&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff1b;&#x9ad8;&#x6e29;&#x7ec4;&#x548c;&#x4e2d;&#x6e29;&#x7ec4;&#x60a3;&#x8005;STM&#x6b63;&#x786e;&#x7387;&#x9ad8;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;STM&#x5e73;&#x5747;&#x53cd;&#x5e94;&#x65f6;&#x95f4;&#x4f4e;&#x4e8e;&#x6cbb;&#x7597;&#x524d;&#xff08;<i>P</i>&lt;0.05&#xff09;&#x3002;&#x6cbb;&#x7597;&#x540e;&#xff0c;&#x9ad8;&#x6e29;&#x7ec4;&#x60a3;&#x8005;MoCA&#x603b;&#x5206;&#x53ca;&#x89c6;&#x7a7a;&#x95f4;&#x4e0e;&#x6267;&#x884c;&#x529f;&#x80fd;&#x3001;&#x8bb0;&#x5fc6;&#x4e0e;&#x5ef6;&#x8fdf;&#x8bb0;&#x5fc6;&#x80fd;&#x529b;&#x3001;&#x6ce8;&#x610f;&#x529b;&#x3001;&#x8bed;&#x8a00;&#x80fd;&#x529b;&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x4e2d;&#x6e29;&#x7ec4;&#x53ca;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;MMSE&#x8bc4;&#x5206;&#x3001;STM&#x6b63;&#x786e;&#x7387;&#x53ca;ROCF&#x77ac;&#x65f6;&#x56de;&#x5fc6;&#x3001;&#x5ef6;&#x8fdf;&#x56de;&#x5fc6;&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x4e2d;&#x6e29;&#x7ec4;&#x53ca;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;STM&#x5e73;&#x5747;&#x53cd;&#x5e94;&#x65f6;&#x95f4;&#x4f4e;&#x4e8e;&#x4e2d;&#x6e29;&#x7ec4;&#x53ca;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;HbA1c&#x503c;&#x4f4e;&#x4e8e;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff1b;&#x4e2d;&#x6e29;&#x7ec4;&#x60a3;&#x8005;MoCA&#x603b;&#x5206;&#x53ca;&#x6ce8;&#x610f;&#x529b;&#x8bc4;&#x5206;&#x3001;MMSE&#x8bc4;&#x5206;&#x9ad8;&#x4e8e;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#xff0c;STM&#x5e73;&#x5747;&#x53cd;&#x5e94;&#x65f6;&#x95f4;&#x4f4e;&#x4e8e;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#x3002;3&#x7ec4;&#x60a3;&#x8005;&#x6cbb;&#x7597;&#x524d;&#x540e;FPG&#x503c;&#x7ec4;&#x5185;&#x3001;&#x7ec4;&#x95f4;&#x6bd4;&#x8f83;&#x5dee;&#x5f02;&#x5747;&#x65e0;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>P</i>&gt;0.05&#xff09;&#x3002;&#x9ad8;&#x6e29;&#x7ec4;&#x3001;&#x4e2d;&#x6e29;&#x7ec4;&#x548c;&#x4f4e;&#x6e29;&#x7ec4;&#x603b;&#x6709;&#x6548;&#x7387;&#x5206;&#x522b;&#x4e3a;75.0%&#xff08;15/20&#xff09;&#x3001;50.0%&#xff08;10/20&#xff09;&#x548c;15.0%&#xff08;3/20&#xff09;&#xff0c;&#x9ad8;&#x6e29;&#x7ec4;&#x603b;&#x6709;&#x6548;&#x7387;&#x9ad8;&#x4e8e;&#x4f4e;&#x6e29;&#x7ec4;&#xff08;<i>P</i>&lt;0.05&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b>&#x4e0d;&#x540c;&#x6e29;&#x5ea6;&#x827e;&#x7078;&#x6cbb;&#x7597;2&#x578b;&#x7cd6;&#x5c3f;&#x75c5;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x51cf;&#x9000;&#x7597;&#x6548;&#x5b58;&#x5728;&#x5dee;&#x5f02;&#xff0c;&#x7078;&#x6e29;&#x4ecb;&#x4e8e;44~46 &#x2103;&#x65f6;&#x5728;&#x63d0;&#x9ad8;&#x8ba4;&#x77e5;&#x529f;&#x80fd;&#x53ca;&#x7a33;&#x5b9a;&#x8fd1;2~3&#x4e2a;&#x6708;&#x7684;&#x5e73;&#x5747;&#x8840;&#x7cd6;&#x6c34;&#x5e73;&#x65b9;&#x9762;&#x66f4;&#x6709;&#x4f18;&#x52bf;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical efficacy</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">moxibustion</Keyword><Keyword MajorTopicYN="N">moxibustion temperature</Keyword><Keyword MajorTopicYN="N">type 2 diabetes mellitus (T2DM)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>18</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>15</Day><Hour>22</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40954052</ArticleId><ArticleId IdType="doi">10.13703/j.0255-2930.20240903-k0006</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>